The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
April 15th 2025
The designation was supported based on data from the randomized, double-blind, active-controlled phase 3 interchangeability study.
AZD0780, Novel Oral PCSK9 Inhibitor, Demonstrates Major LDL Cholesterol Reductions
April 11th 2025When used in combination with background statin therapy, AZD0780 resulted in major reductions in low-density lipoprotein cholesterol (LDL-C) and achievements of guideline-recommended LDL-C goals.
Read More
Financial Incentives for COVID-19 Vaccination May Have Adverse Spillover Effects on Booster Uptake
April 9th 2025Monetary incentives to receive a COVID-19 vaccine at a public vaccination event may have inadvertently turned away others from receiving a booster, emphasizing the importance of recognizing spillover in trials addressing vaccine hesitancy.
Read More
Long-Term Tirzepatide Demonstrates Benefits in Patients With CKD, Obesity, and HFpEF
April 7th 2025Tirzepatide-treated patients with chronic kidney disease (CKD), obesity, and heart failure with preserved ejection fraction (HFpEF) had improved renal function both by cystatin C and creatinine.
Read More